TerrAscend Increases 2023 Adjusted EBITDA Guidance By 8% To $63 Million

TerrAscend Corp (TSX: TSND) has raised guidance ahead of the launch of an investor day in Toronto scheduled for today.

The company this morning lifted guidance on both net revenues and adjusted EBITDA from continuing operations for 2023. Net revenue guidance has been bumped by 3.9%, from at least $305 million to at least $317 million.

Adjusted EBITDA guidance meanwhile has improved by 8.6%, with TerrAscend now calling for Adjusted EBITDA of at least $63 million, versus the prior guidance of at least $58 million.

The figures represent year over year growth of 28% and 62%, respectively. Gross margins are also expected to exceed 50%, while free cash flow from operations is expected to be positive for the second half of the year.

“We expect to drive industry leading revenue growth, continued improvement across all P&L metrics, and positive free cashflow in the second half of the year,” commented executive chairman Jason Wild.

TerrAscend last traded at $2.51 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

Total Metals Launches 5,500 Metre Drill Program At ElectroLode Property

Mercado Minerals Launches Two Phase Geophysical Program At Copalito Project

Related News

TerrAscend Conducts $224 Million Financing Largely Sourced From US Institutions

TerrAscend Corp (CSE: TER) is the latest US cannabis operator to announce a significant capital...

Tuesday, January 12, 2021, 07:53:03 AM

TerrAscend Looks To Raise US$20 Million

TerrAscend Corp (CSE: TER) announced this morning that it intends to raise US$20 million via...

Tuesday, December 10, 2019, 09:39:44 AM

US Cannabis: Stifel Expects Growth To Decelerate In Q4 Earnings

On February 2nd, Stifel-GMP put out their fourth quarter 2021 earnings preview, calling it “The...

Wednesday, February 9, 2022, 04:33:00 PM

TerrAscend: Analysts Expect $57.4 Million In First Quarter Revenues

TerrAscend Corp (CSE: TER) announced that they will be reporting their first quarter financials before...

Tuesday, May 18, 2021, 02:43:00 PM

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM